Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10295290 | 1.00 | MAPT (0.50) | MAPTRAB9AGRM2L3MBTL1TDP1 | |
| SCHEMBL10295291 | 0.87 | TP53 (0.49) | L3MBTL1TDP1MEN1ALDH1A1HTT | |
| SCHEMBL10295295 | 0.87 | TP53 (0.49) | L3MBTL1TDP1MEN1ALDH1A1HTT | |
| SCHEMBL17718052 | 0.87 | LMNA (0.41) | MAPTKDM4EALDH1A1KMT2AGAA | |
| SCHEMBL10295216 | 0.87 | LMNA (0.40) | MAPTGRM2L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10295204 | 0.87 | LMNA (0.40) | MAPTGRM2L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10295242 | 0.87 | LMNA (0.40) | MAPTGRM2L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10295185 | 0.87 | LMNA (0.40) | MAPTGRM2L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10295234 | 0.87 | LMNA (0.40) | MAPTGRM2L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10295168 | 0.86 | LMNA (0.39) | MAPTL3MBTL1KDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8535769-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and oriented film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-17 | — | — | US | disclosed |
| US-20120172560-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, AND ORIENTED FILM | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172560-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, AND ORIENTED FILM | CRY1, NAP1L1, LAS1L | MAPT 153/4885RAB9A 1814/4885GRM2 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.